Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study.

@article{Olin1999MedicalCO,
  title={Medical costs of treating venous stasis ulcers: evidence from a retrospective cohort study.},
  author={Jeffrey W. Olin and Kathleen Marie Beusterien and Mary Beth Childs and Carol Seavey and Lois McHugh and Robert I. Griffiths},
  journal={Vascular medicine},
  year={1999},
  volume={4 1},
  pages={1-7}
}
Venous stasis ulcers (VSU) account for approximately 80-90% of lower extremity ulcerations. Given their prevalence and chronic nature, VSU are thought to impose a significant economic burden on Medicare (the USA's largest health insurance program) and other third party payers. However, comprehensive studies on the costs of VSU treatment are lacking. The objective of this study therefore was to examine comprehensively the direct medical costs of treating patients with a VSU in routine clinical… CONTINUE READING